At the time of this writing, only one cannabis-derived product has been approved by the FDA: Epidiolex, a drug containing CBD, is administered to patients two years of age and older as a treatment for seizures. The FDA currently prohibits the marketing of any CBD product as a treatment for any disease or condition and emphasizes that some manufacturers of CBD products are not abiding by FDA standards and are potentially putting consumers at risk.
The endocannabinoid system by which CBD enacts its effects is present in all mammals, birds, reptiles, and fish. This includes cats and dogs, which are known to experience many of the same medical and emotional issues as humans. It is therefore logical – and widely anecdotally supported – to suggest that CBD can help our pets manage anxiety, stress, pain, nausea, and other ailments. NuLeaf Naturals believes in the power of CBD for pets and offers a CBD pet tincture for use with your furry friend or friends.
While sometimes used interchangeably, CBD oil and hemp oil are different. While they both come from hemp, CBD is derived from mostly the flowers or buds – although full plant extracts use the entire plant. Hemp seed oil, on the other hand, is derived solely from the seeds of the plant and contains no cannabinoids.
The Market for CBD is Expected to Reach $20 Billion By 2024
As the market for CBD products and public interest overall continues to grow, more and more consumers are seeking out reliable information regarding CBD itself. To help set the record straight, here are ten important CBD facts that you should know.
As if the growing market for CBD weren’t already obvious enough, a recent study by BDS Analytics projects the overall market to reach and surpass $20 billion by 2024. This constitutes a compound annual growth rate of 49 percent, making the total market for all cannabis products (CBD and THC) reach $45 billion by 2024.
Though much is already known about CBD and its effects, much remains to be discovered. There is an ongoing global shift in attitudes regarding how CBD is viewed both as a drug and a consumer commodity, whereupon continued scientific study is shedding more light on its therapeutic potential while discrediting the negative stigmas of the past.
Because full spectrum CBD oil interacts with cannabinoid receptors in the brain, it’s not entirely accurate to describe it as non-psychoactive. However, it will not induce the sense of euphoria for which it’s cousin, THC, is so well-known.
According to the World Health Organization CBD is generally tolerated by most humans. It has a good safety profile and the U.S. Food and Drug Administration has even approved an oral CBD product, Epidiolex, as a treatment for Lennox-Gastaut and Dravet syndromes – two severe childhood-onset seizure disorders.
People with CECD produce a lower amount of natural cannabinoids. The negative effects of this decreased production could be:
Anxiety is most commonly treated through the administration of medication, psychotherapy, or both. A 2018 survey in Cannabis and Cannabinoid Research states that over 60% of cannabidiol users reported they were taking CBD to treat a medical condition. The most prevalent conditions these users reported were pain, anxiety, and depression.
Here are 10 science-based CBD facts that everyone needs to know.
As stated before, the pharmaceuticals prescribed for these conditions can cause side effects worse than the symptoms. This is another area where CBD can naturally, and side effect free, increase cannabinoids in the body to promote greater health.
10.) CBD can naturally help those suffering from seizures and epilepsy
CBD is a natural product that can be derived from industrial hemp plants. Though the legal use of cannabis is different depending on location, CBD is free from these regulations due to the minuscule THC content that industrial hemp plants contain (less than .3%).
Tired of tossing and turning? There are some strategies you could try to improve your hours in bed.
Cannabidiol and THC are just two of the plant’s more than 100 cannabinoids. THC is psychoactive, and CBD may or may not be, which is a matter of debate. THC can increase anxiety; it is not clear what effect CBD is having, if any, in reducing it. THC can lead to addiction and cravings; CBD is being studied to help those in recovery.
Last year, the F.D.A. approved Epidiolex, a purified CBD extract, to treat rare seizure disorders in patients 2 years or older after three randomized, double-blind and placebo-controlled clinical trials with 516 patients that showed the drug, taken along with other medications, helped to reduce seizures. These types of studies are the gold standard in medicine, in which participants are divided by chance, and neither the subject nor the investigator knows which group is taking the placebo or the medication.
Does CBD work?
Up in the wee hours of the night, stuck watching videos of puppies? CBD may be promising as a sleep aid; one of the side effects of the Epidiolex trials for epilepsy was drowsiness, according to Mr. MacKillop, a co-author of a review on cannabinoids and sleep. “If you are looking for new treatments for sleep, that may be a clue,” he said.
But he cautions that the side effects could have been because of an interaction with other medications the children were taking to control the seizures. So far, there hasn’t been a randomized, placebo-controlled, double-blind trial (the gold standard) on sleep disorders and CBD.
Earlier research found fewer than a third of 84 products studied contained the amount of CBD on their labels. Some users of CBD have also failed drug tests when the product contained more THC than indicated.
CBD is advertised as providing relief for anxiety, depression and post-traumatic stress disorder. It is also marketed to promote sleep. Part of CBD’s popularity is that it purports to be “nonpsychoactive,” and that consumers can reap health benefits from the plant without the high (or the midnight pizza munchies).